The Thermo Scientific Capillary Flow LC MS Solutions

Significance of the Topic

Capillary-flow liquid chromatography–mass spectrometry (CapLC-MS) merges the high sensitivity of nano-flow with the robust throughput of analytical-flow platforms. This hybrid approach is vital for proteomics research, bioanalytical assays, QA/QC workflows and clinical applications where both detection limits and sample throughput are critical.

Study Goals and Overview

The document presents the Thermo Scientific Capillary-Flow LC-MS solution and demonstrates its performance in various workflows. Key objectives include:

• Describing the UltiMate 3000 RSLCnano platform adapted for capillary-flow rates (1–15 µL/min).
• Comparing capillary versus nano LC in data-dependent (DDA) and data-independent (DIA) proteomics.
• Illustrating quantitative assays for monoclonal antibodies, small molecules in plasma, and peptide standards.
• Evaluating throughput, reproducibility, and method flexibility.

Methodology and Instrumentation

The capillary-flow solution couples an UltiMate 3000 RSLCnano UHPLC with nanoViper fittings and EASY-Spray emitters. Two ESI sources are supported: EASY-Spray for optimal performance and Ion Max HESI for low-flow applications. Sample introduction can be via pre-concentration with trap cartridges or direct injection. The system accommodates a broad column portfolio (150–320 µm ID; 1.9–5 µm particles) including Thermo Scientific and third-party phases. Software control is available through Chromeleon CDS, Xcalibur, TraceFinder and Thermo’s native driver.

• UHPLC: UltiMate 3000 RSLCnano
• ESI Sources: EASY-Spray, Ion Max HESI
• Mass Spectrometers: Q Exactive HF, Q Exactive Focus, TSQ Quantiva
• Software: Chromeleon CDS, Xcalibur, TraceFinder, Spectronaut

Main Results and Discussion

Proteomics analyses show that capillary-flow DDA yields ~2 200 protein IDs in 60 min (≈80% of nano LC). DIA experiments at 5 µL/min identified >27 000 peptide precursors and >4 000 proteins at 1% FDR. Targeted PRM quantification of infliximab achieved a 16 amol limit in buffer and low-fmol detection in complex matrices, with linear dynamic range spanning five orders of magnitude. Small molecule assays in rat plasma delivered a threefold signal boost versus analytical flow. Insulin quantitation transferred seamlessly from microflow workflows, enhancing signal with stable peak shapes. High-throughput operation using 10 min gradients allowed ~16 min cycle times with minimal compromise in separation. Comparative tests of pre-concentration and direct injection modes confirmed equivalent retention time precision (RSD <1%) and peak widths; direct injection is recommended for highly hydrophilic analytes. Trap loading volumes up to 75 µL effectively desalt samples without degrading performance for standard peptides, though very early eluents may exhibit partial loss.

Benefits and Practical Applications

• Balanced sensitivity and throughput for large-cohort proteomics and bioanalysis.
• High reproducibility over hundreds of injections.
• Versatile for both untargeted and targeted workflows.
• Compatibility with various column chemistries and MS instruments.

Future Trends and Possibilities

Continued integration with high-resolution mass analyzers, advanced automation of trap switching, further miniaturization, AI-driven method optimization, and expansion into clinical diagnostics and large-scale biomarker studies are expected to enhance CapLC-MS utility.

Conclusion

The Thermo Scientific Capillary-Flow LC-MS solution offers a robust compromise between nano-flow sensitivity and analytical flow robustness. Its demonstrated performance in proteomics, targeted quantitation and small molecule analysis establishes it as a versatile platform for high-throughput, high-sensitivity applications.

References

No formal literature references were provided in the original document.